Synbio Tech Inc. (TPEX:1295)
Taiwan
· Delayed Price · Currency is TWD 93.70
-1.20 (-1.26%)
At close: Dec 5, 2025
Synbio Tech Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 1,001 | 989.48 | 823.3 | 739.33 |
| Revenue Growth (YoY) | 2.61% | 20.18% | 11.36% | - |
| Cost of Revenue | 459.95 | 448.64 | 404.56 | 378 |
| Gross Profit | 540.63 | 540.84 | 418.75 | 361.33 |
| Selling, General & Admin | 238.54 | 222.88 | 275.79 | 259.49 |
| Research & Development | 114.04 | 108.57 | - | - |
| Operating Expenses | 352.72 | 331.45 | 275.79 | 259.82 |
| Operating Income | 187.91 | 209.4 | 142.96 | 101.5 |
| Interest Expense | -7.02 | -3.71 | -6.6 | -7.69 |
| Interest & Investment Income | 10.06 | 9.27 | 7.34 | 6.54 |
| Currency Exchange Gain (Loss) | - | - | -3.16 | 10.08 |
| Other Non Operating Income (Expenses) | 2.21 | 21.64 | 6.58 | 5.27 |
| EBT Excluding Unusual Items | 193.16 | 236.59 | 147.12 | 115.7 |
| Gain (Loss) on Sale of Assets | - | - | -0.06 | - |
| Pretax Income | 193.16 | 236.59 | 147.07 | 115.7 |
| Income Tax Expense | 37.56 | 66.47 | 33.8 | 23.18 |
| Net Income | 155.61 | 170.13 | 113.27 | 92.52 |
| Net Income to Common | 155.61 | 170.13 | 113.27 | 92.52 |
| Net Income Growth | -13.48% | 50.19% | 22.43% | - |
| Shares Outstanding (Basic) | 32 | 31 | 31 | 31 |
| Shares Outstanding (Diluted) | 33 | 32 | 31 | 31 |
| Shares Change (YoY) | 3.83% | 0.02% | 0.02% | - |
| EPS (Basic) | 4.79 | 5.43 | 3.61 | 2.96 |
| EPS (Diluted) | 4.77 | 5.40 | 3.60 | 2.94 |
| EPS Growth | -16.57% | 50.08% | 22.33% | - |
| Free Cash Flow | -361.68 | -40.62 | -113.36 | -29.54 |
| Free Cash Flow Per Share | -11.09 | -1.29 | -3.60 | -0.94 |
| Dividend Per Share | - | 3.500 | 1.471 | 1.961 |
| Dividend Growth | - | 138.00% | -25.00% | - |
| Gross Margin | 54.03% | 54.66% | 50.86% | 48.87% |
| Operating Margin | 18.78% | 21.16% | 17.36% | 13.73% |
| Profit Margin | 15.55% | 17.19% | 13.76% | 12.51% |
| Free Cash Flow Margin | -36.15% | -4.11% | -13.77% | -4.00% |
| EBITDA | 261.79 | 285.44 | 215.04 | 173.4 |
| EBITDA Margin | 26.16% | 28.85% | 26.12% | 23.45% |
| D&A For EBITDA | 73.88 | 76.04 | 72.08 | 71.9 |
| EBIT | 187.91 | 209.4 | 142.96 | 101.5 |
| EBIT Margin | 18.78% | 21.16% | 17.36% | 13.73% |
| Effective Tax Rate | 19.44% | 28.09% | 22.98% | 20.03% |
Source: S&P Capital IQ. Standard template. Financial Sources.